September 26, 2017

European Commission Approves Symtuza® for the Treatment...

(AETOS Wire)-- Janssen-Cilag International NV (Janssen) today announced that the European Commission has approved the use of Symtuza® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF])1, a once-daily darunavir-based single-tablet"...

Read More >
September 25, 2017

NMC acquisition of three hospitals in KSA gets green light...

  • NMC receives all regulatory approvals for long-term care facility in Jeddah
  • Agrees to terms to acquire two new profitable hospitals
  • Plans for a new 170-bed greenfield facility

"...

Read More >
September 20, 2017

WHO: 700,000 cases of cholera in Yemen

Some 700,000 suspected cases of cholera have hit Yemen, with the outbreak showing no signs of rescinding, the WHO has reported.

In its plan to tackle the disease, the organisation has planned to distribute vaccines"...

Read More >
September 18, 2017

IPF World Week 2017: Boehringer Ingelheim helps healthcare...

(AETOS Wire)-- IPF is a progressive and debilitating disease which causes continual and irreversible damage to the lungs.1 Early diagnosis is vital because without appropriate medical intervention, the opportunity to slow disease progression is lost."...

Read More >
September 18, 2017

CHMP positive opinion to include RE-CIRCUIT® data for...

  • The CHMP of the EMA has issued a positive opinion for an update of the Summary of Product Characteristics (SmPC) for Pradaxa® (dabigatran etexilate)
  • The CHMP recommends to include data showing that catheter ablation can be conducted in patients on 150 mg twice daily Pradaxa®, without interrupting Pradaxa® treatment
  • ...

    Read More >
September 17, 2017

Bioventus Announces First Patients Enrolled in BONES Study...

(AETOS Wire) -- Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in its BONES (Bioventus Observational Non-interventional EXOGEN Studies) clinical development program. BONES includes three observational, non-interventional, direct-to-patient studies designed to collect real world data on the use of the EXOGEN Ultrasound Bone Healing System. EXOGEN uses safe, effective low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process. The BONES studies will compare the incidence of fracture nonunions in patients utilizing EXOGEN with patients from a national......

Read More >
September 15, 2017

Boehringer Ingelheim receives positive CHMP opinion for...

  • Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cyltezo® (adalimumab biosimilar) for the treatment of multiple chronic inflammatory diseases
  • Recommendation based on extensive analytical, pharmacological, non –clinical & clinical data, which demonstrated...

    Read More >
September 15, 2017

Global Foundation Launches to Accelerate an End to Smoking...

Foundation for a Smoke-Free World Secures Major 12 Year Funding Commitment; Shares Initial Plans to Reduce Harm and Deaths from Smoking Worldwide (AETOS Wire)-- With the goal of eliminating smoking worldwide, the Foundation for a Smoke-Free World formally launched today in New York City. The Foundation is founded and led by Dr. Derek Yach, a renowned anti-smoking crusader who, while at the World Health Organization (WHO), was the primary architect of the WHO’s Framework Convention on Tobacco Control. The Foundation will build upon......

Read More >
September 15, 2017

Two New Innovative Swiss Made EDOF IOLs for Cataract Surgery...

(AETOS Wire)-- The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both using the Instant Focus EDOF patented technology. With a brand-new concept,"...

Read More >
September 13, 2017

Life Line Screening Expands Product Base to DNA, Clinical...

(AETOS Wire)-- Life Line Screening, a leader in community-based preventive healthcare, is deepening its delivery model of face-to-face patient care to provide access to advanced precision medicine through DNA testing and clinical trials.

This"...

Read More >
Found articles: - Pages